RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000083.xml
Synlett 2012; 23(17): 2449-2452
DOI: 10.1055/s-0032-1317180
DOI: 10.1055/s-0032-1317180
letter
Regioselective Syntheses of 2,7-(Het)Arylpyrido[2,3-d]pyrimidines by an Orthogonal Cross-Coupling Strategy
Weitere Informationen
Publikationsverlauf
Received: 10. Juni 2012
Accepted after revision: 15. August 2012
Publikationsdatum:
13. September 2012 (online)
Abstract
An efficient and easy access to 2,7-disubstituted pyrido[2,3-d]pyrimidine derivatives is reported. These derivatives were obtained using two orthogonal palladium-catalyzed cross-coupling reactions via successive C-7 chlorine and C-2 methylsulfur releases.
-
References and Notes
- 1a Reck F, Alm R, Brassil P, Newman J, DeJonge B, Eyermann CJ, Breault G, Breen J, Comita-Prevoir J, Cronin MDavis H, Ehmann D, Galullo V, Geng B, Grebe T, Morningstar M, Walker P, Hayter B, Fisher S. J. Med. Chem. 2011; 54: 7834
- 1b DeGraw JI, Kisliuk RL, Gaumont Y, Baugh CM. J. Med. Chem. 1974; 17: 470
- 1c Matsumoto J, Minami S. J. Med. Chem. 1975; 18: 74
- 1d Rajesh SM, Kumar RS, Libertsen LA, Perumal S, Yogeeswari P, Sriram D. Bioorg. Med. Chem. Lett. 2011; 21: 3012
- 1e Grivsky EM, Lee S, Sigel CW, Duch DS, Nichol CA. J. Med. Chem. 1980; 23: 327
- 1f Ghilsoo N, Cheol MY, Euikyung K, Chung KR, Joong HK, Jung HS, Sung HK. Bioorg. Med. Chem. Lett. 2001; 11: 611
- 1g Singh G, Singh G, Yadav AK, Mishra AK. Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem. 2002; 41: 430
- 1h Liu KK, Huang X, Bagrodia S, Chen JH, Greasley S, Cheng H, Sun S, Knighton D, Rodgers C, Rafidi K, Zou A, Xiao J, Yan S. Bioorg. Med. Chem. Lett. 2011; 21: 1270
- 1i El-Subbagh H, Abu-Zaid SM, Mahran MA, Badria FA, Al-Obaid AM. J. Med. Chem. 2000; 43: 2915
- 2 Sako M In Science of Synthesis . Vol. 16. Yamamoto Y. Thieme; Stuttgart: 2004: 1155
- 3a Tikad A, Routier S, Akssira M, Leger J.-M, Jarry C, Guillaumet G. Org. Lett. 2007; 9: 4673
- 3b Tikad A, Routier S, Akssira M, Guillaumet G. Org. Biomol. Chem. 2009; 7: 5113
- 3c Riadi Y, Massip S, Leger JM, Jarry C, Lazar S, Guillaumet G. Tetrahedron 2012; 68: 5018
- 4a Kusturin C, Liebeskind LS, Rahman H, Sample K, Schweitzer B, Srogl J, Neumann WL. Org. Lett. 2003; 5: 4349
- 4b Bouscary-Desforges G, Bombrun A, Augustine JK, Bernardinelli G, Quattropani A. J. Org. Chem. 2012; 77: 243
- 4c Bouscary-Desforges G, Bombrun A, Augustine JK, Bernardinelli G, Quattropani A. J. Org. Chem. 2012; 77: 4586
- 5 Boothe R. J., Dobrusin E. M., Josyula V. P. V. N., McNamara D. J., Toogood P. L.; WO 01/55147 A1, 2001; Chem. Abstr. 2001, 135, 152817.
- 6a Miyaura N, Yamada K, Suzuki A. Tetrahedron Lett. 1979; 36: 3437
- 6b Miyaura N, Suzuki A. Chem. Rev. 1995; 36: 2457
- 7 General Procedure for the Preparation of Compounds 3a–j. 7-Chloro-2-methylsulfanylpyrido[2,3-d]pyrimidine5 (1, 0.5 mmol), boronic acid (1.1 equiv), and Na2CO3 (2.0 equiv) were dissolved in a mixture of toluene–EtOH (6:3 mL). After argon bubbled, Pd(PPh3)4 (0.05 equiv) was added, and the reaction mixture was refluxed for 18 h. The reaction mixture was then cooled to r.t., and the solvent was removed under reduced pressure. Desired compounds 3 were directly obtained after purification by flash silica gel chromatography (eluent PE–EtOAc, 8:2 to 1:1).7-(4-Methoxyphenyl)-2-methylsulfanylpyrido[2,3-d]pyrimidine (3a)Yield 73%; yellow solid; mp 163–165 °C. IR (ATR): 3051, 2929, 1584, 1512, 1462 cm–1. 1H NMR (400 MHz, CDCl3): δ = 2.73 (s, 3 H), 3.86 (s, 3 H), 6.99 (d, J = 8.0 Hz, 2 H), 7.84 (d, J = 8.0 Hz, 1 H), 8.12 (d, J = 8.0 Hz, 1 H), 8.19 (d, J = 8.0 Hz, 2 H), 9.06 (s, 1 H). 13C NMR (100 MHz, CDCl3): δ = 14.7 (CH3), 55.6 (CH3), 114.4 (2 CH), 115.5 (Cq), 119.1 (CH), 130.1 (2 CH), 130.4 (Cq), 137.1 (CH), 158.9 (Cq), 160.4 (CH), 162.3 (Cq), 164.6 (Cq), 173.9 (Cq). HRMS (EI-MS): m/z calcd for C15H13N3OS: 284.08558 [M + H+]; found: 284.08521.
- 8a Alphonse F.-A, Suzenet F, Keromnes A, Lebret B, Guillaumet G. Synlett 2002; 447
- 8b Liebeskind LS, Srogl J. Org. Lett. 2002; 4: 979
- 8c Prokopcova H, Kappe OC. Angew. Chem. Int. Ed. 2009; 48: 2276
- 9a Omouch S, Bourotte M, Schmitt M, Bourguignon J.-J. Synthesis 2005; 25
- 9b Leconte N, Keromnes-Wuillaume A, Suzenet F, Guillaumet G. Synlett 2007; 204
- 10 General Procedure for the Preparation of Compounds 4a–mIn a sealed tube and under argon, 7-aryl-2-methylsulfanylpyrido[2,3-d]pyrimidine 3 (0.3 mmol), boronic acid (2.2 equiv), and CuTC (2.2 equiv) were dissolved in dry DME (3 mL). Pd(PPh3)4 (0.05 equiv) was added, and the reaction mixture was stirred under microwave irradiation at 200 °C for 1 h. After cooling to r.t., the reaction mixture was poured into a sat. aq NaHCO3 solution (20 mL) and the aqueous layer extracted with CH2Cl2 (3 × 20 mL). The combined organic phases were dried over MgSO4, and the solvent was removed under reduced pressure. Desired compounds 4 were purified by flash silica gel chromatography (CH2Cl2–MeOH, 100:0 to 98:2).7-(4-Methoxyphenyl)-2-phenylpyrido[2,3-d]pyrimidine (4a)Yield 79%; white solid; mp 313–314 °C. IR (ATR): 3061, 2990, 2834, 1517, 1435 cm–1. 1H NMR (400 MHz, CDCl3): δ = 3.89 (s, 3 H), 7.03 (d, J = 8.8 Hz, 2 H), 7.50–7.54 (m, 3 H), 7.97 (d, J = 8.5 Hz, 1 H), 8.24 (d, J = 8.5 Hz, 1 H), 8.28 (d, J = 8.8 Hz, 2 H), 8.70–8.73 (m, 2 H), 9.42 (s, 1 H). 13C NMR (100 MHz, CDCl3): δ = 55.6 (CH3), 114.5 (2 CH), 117.0 (Cq), 120.2 (CH), 128.7 (2 CH), 129.4 (2 CH), 130.2 (2 CH), 130.6 (Cq), 131.4 (CH), 136.7 (CH), 137.6 (Cq), 159.3 (Cq), 161.2 (CH), 162.4 (Cq), 164.8 (Cq), 165.1 (Cq). HRMS (EI-MS): m/z calcd for C20H15N3O: 314.1288 [M + H+]; found: 314.1292.
- 11 Routier S., Guillaumet G., Tikad A., Dehbi O.; WO 2011/135259, 2011; Chem. Abstr. 2011, 155, 637809.